{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Laval",
      "state": "",
      "country": "Canada",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65954",
      "recalling_firm": "Sanofi-Synthelabo",
      "address_1": "2150 Boul Saint Elzear O",
      "address_2": "",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Canada",
      "recall_number": "D-886-2013",
      "product_description": "Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manufactured by: Fabrique par Sanofi-Aventis Canada Inc., Laval, Quebec, Canada H7L4A8, DIN # 02091887",
      "product_quantity": "998 Bottles",
      "reason_for_recall": "Subpotent Drug:  During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.",
      "recall_initiation_date": "20130226",
      "center_classification_date": "20130813",
      "termination_date": "20140606",
      "report_date": "20130821",
      "code_info": "Lot # 3099036, Exp 03/2014",
      "more_code_info": ""
    }
  ]
}